Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Nattermann

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
Journal of Hepatology|June 28, 2011
The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutationJacob Nattermann, Jörg Timm, Hans Dieter Nischalke, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patientsJacob Nattermann, Martin Vogel, Thomas Berg, et al.
Journal of Hepatology|April 29, 2014
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infectionMohammed Eslam, Reynold Leung, Manuel Romero-Gomez, et al.
The Journal of Infectious Diseases|March 24, 2022
Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After VaccinationGereon J Rieke, Kathrin van Bremen, Jenny Bischoff, et al.
The Journal of Infectious Diseases|January 25, 2011
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis CJacob Nattermann, Martin Vogel, Hans Dieter Nischalke, et al.
Scientific Reports|January 20, 2022
Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapyMaria A Gonzalez-Carmona, Christian Möhring, Robert Mahn, et al.
Hepatology (Baltimore, Md.)|April 7, 2023
Identification and characterization of a hepatic IL-13-producing ILC3-like population potentially involved in liver fibrosisJan Raabe, Kim M Kaiser, Michael ToVinh, et al.
Nature Communications|February 25, 2021
SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activityNicolas Huot, Philippe Rascle, Caroline Petitdemange, et al.
United European Gastroenterology Journal|April 28, 2022
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registryJonathan F Brozat, Frank Hanses, Martina Haelberger, et al.
BMC Cancer|May 26, 2020
Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort studyKarolin Bucksch, Silke Zachariae, Stefan Aretz, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
Journal of Hepatology|June 28, 2011
The predictive value of IL28B gene polymorphism for spontaneous clearance in a single source outbreak cohort is limited in patients carrying the CCR5Δ32 mutationJacob Nattermann, Jörg Timm, Hans Dieter Nischalke, et al.
Hepatology (Baltimore, Md.)|August 3, 2007
Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patientsJacob Nattermann, Martin Vogel, Thomas Berg, et al.
Journal of Hepatology|April 29, 2014
IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infectionMohammed Eslam, Reynold Leung, Manuel Romero-Gomez, et al.
The Journal of Infectious Diseases|March 24, 2022
Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity Against SARS-CoV-2 After Natural Infection Is More Potent Than After VaccinationGereon J Rieke, Kathrin van Bremen, Jenny Bischoff, et al.
The Journal of Infectious Diseases|January 25, 2011
Genetic variation in IL28B and treatment-induced clearance of hepatitis C virus in HIV-positive patients with acute and chronic hepatitis CJacob Nattermann, Martin Vogel, Hans Dieter Nischalke, et al.
Scientific Reports|January 20, 2022
Impact of regular additional endobiliary radiofrequency ablation on survival of patients with advanced extrahepatic cholangiocarcinoma under systemic chemotherapyMaria A Gonzalez-Carmona, Christian Möhring, Robert Mahn, et al.
Hepatology (Baltimore, Md.)|April 7, 2023
Identification and characterization of a hepatic IL-13-producing ILC3-like population potentially involved in liver fibrosisJan Raabe, Kim M Kaiser, Michael ToVinh, et al.
Nature Communications|February 25, 2021
SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activityNicolas Huot, Philippe Rascle, Caroline Petitdemange, et al.
United European Gastroenterology Journal|April 28, 2022
COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registryJonathan F Brozat, Frank Hanses, Martina Haelberger, et al.
BMC Cancer|May 26, 2020
Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort studyKarolin Bucksch, Silke Zachariae, Stefan Aretz, et al.
Pageof 16